Companies in #Movement Disorders

Newronika is a Milan-based medtech company pioneering adaptive deep brain stimulation (aDBS) therapy. Their αDBS platform received CE Mark certification in July 2026, advancing adaptive DBS as a new standard of care for Parkinson's disease and other movement disorders.

Praxis Precision Medicines is a clinical-stage biopharmaceutical company translating genetic insights into precision therapies for central nervous system (CNS) disorders, with a focus on epilepsy and broader neuroscience.